• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

走向血管结缔组织疾病的精准医学。

Toward precision medicine in vascular connective tissue disorders.

机构信息

Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

出版信息

Am J Med Genet A. 2021 Nov;185(11):3340-3349. doi: 10.1002/ajmg.a.62461. Epub 2021 Aug 24.

DOI:10.1002/ajmg.a.62461
PMID:34428348
Abstract

Tremendous progress has been made in understanding the etiology, pathogenesis, and treatment of inherited vascular connective tissue disorders. While new insights regarding disease etiology and pathogenesis have informed patient counseling and care, there are numerous obstacles that need to be overcome in order to achieve the full promise of precision medicine. In this review, these issues will be discussed in the context of Marfan syndrome and Loeys-Dietz syndrome, with additional emphasis on the pioneering contributions made by Victor McKusick.

摘要

在理解遗传性血管结缔组织疾病的病因、发病机制和治疗方面已经取得了巨大的进展。尽管关于疾病病因和发病机制的新见解为患者咨询和护理提供了信息,但为了充分实现精准医学的承诺,仍有许多障碍需要克服。在这篇综述中,将在马凡综合征和洛伊茨-迪茨综合征的背景下讨论这些问题,并特别强调维克托·麦克库斯克的开创性贡献。

相似文献

1
Toward precision medicine in vascular connective tissue disorders.走向血管结缔组织疾病的精准医学。
Am J Med Genet A. 2021 Nov;185(11):3340-3349. doi: 10.1002/ajmg.a.62461. Epub 2021 Aug 24.
2
[Marfan syndrome and related connective tissue disorders].[马凡综合征及相关结缔组织疾病]
Praxis (Bern 1994). 2013 Nov 27;102(24):1483-8. doi: 10.1024/1661-8157/a001496.
3
Unraveling the genetic collagen connection: clinical and therapeutic insights on genetic connective tissue disorders.解开基因胶原蛋白的联系:遗传性结缔组织疾病的临床和治疗见解。
Adv Rheumatol. 2024 Apr 25;64(1):32. doi: 10.1186/s42358-024-00373-z.
4
Expanding the phenotypic spectrum of Mendelian connective tissue disorders to include prominent kidney phenotypes.扩大孟德尔结缔组织疾病的表型谱,包括突出的肾脏表型。
Am J Med Genet A. 2021 Dec;185(12):3762-3769. doi: 10.1002/ajmg.a.62449. Epub 2021 Aug 6.
5
[The Marfan syndrome and related connective tissue disorders].[马凡综合征及相关结缔组织疾病]
Med Monatsschr Pharm. 2009 Jun;32(6):213-9.
6
Chiari I Malformations and the Heritable Disorders of Connective Tissue.Chiari I 畸形与结缔组织遗传性疾病。
Neurosurg Clin N Am. 2023 Jan;34(1):61-65. doi: 10.1016/j.nec.2022.09.001.
7
Perioperative management and considerations in pediatric patients with connective tissue disorders undergoing cardiac surgery.小儿结缔组织疾病患者心脏手术的围手术期处理及注意事项。
Paediatr Anaesth. 2021 Jul;31(7):820-826. doi: 10.1111/pan.14196. Epub 2021 May 13.
8
Intracranial Arterial Tortuosity in Marfan Syndrome and Loeys-Dietz Syndrome: Tortuosity Index Evaluation Is Useful in the Differential Diagnosis.马凡综合征和洛伊茨-迪茨综合征的颅内动脉迂曲:迂曲指数评估有助于鉴别诊断。
AJNR Am J Neuroradiol. 2020 Oct;41(10):1916-1922. doi: 10.3174/ajnr.A6732. Epub 2020 Aug 20.
9
Recent molecular biological progress in Marfan syndrome and Marfan-associated disorders.马凡综合征及相关疾病的最新分子生物学进展。
Ageing Res Rev. 2010 Jul;9(3):363-8. doi: 10.1016/j.arr.2009.09.001. Epub 2009 Sep 17.
10
Analysis of TGFBR1*6A variant in individuals evaluated for Marfan syndrome.对因马凡综合征接受评估的个体中TGFBR1*6A变体的分析。
Am J Med Genet A. 2016 Jul;170(7):1786-90. doi: 10.1002/ajmg.a.37668. Epub 2016 Apr 26.

引用本文的文献

1
Clinical-Genomic Analysis of 1261 Patients with Ehlers-Danlos Syndrome Outlines an Articulo-Autonomic Gene Network (Entome).1261例埃勒斯-当洛综合征患者的临床基因组分析勾勒出一个关节自主基因网络(Entome)。
Curr Issues Mol Biol. 2024 Mar 19;46(3):2620-2643. doi: 10.3390/cimb46030166.
2
Festschrift for Victor A. McKusick on the Centenary of his Birth: Introduction.《维克多·A·麦库西克诞辰一百周年纪念文集:引言》
Am J Med Genet A. 2021 Nov;185(11):3189-3192. doi: 10.1002/ajmg.a.62441. Epub 2021 Aug 2.

本文引用的文献

1
Patient-specific computational evaluation of stiffness distribution in ascending thoracic aortic aneurysm.升主动脉瘤中僵硬度分布的患者特异性计算评估。
J Biomech. 2021 Apr 15;119:110321. doi: 10.1016/j.jbiomech.2021.110321. Epub 2021 Feb 19.
2
Thoracic aortic aneurysms in patients with heritable connective tissue disease.遗传性结缔组织疾病患者的胸主动脉瘤。
J Card Surg. 2021 Mar;36(3):1083-1090. doi: 10.1111/jocs.15340. Epub 2021 Jan 21.
3
Significance of Hemodynamics Biomarkers, Tissue Biomechanics and Numerical Simulations in the Pathogenesis of Ascending Thoracic Aortic Aneurysms.
升主动脉瘤发病机制中心血管血流动力学生物标志物、组织生物力学和数值模拟的意义。
Curr Pharm Des. 2021;27(16):1890-1898. doi: 10.2174/1381612826999201214231648.
4
Aortic "Disease-in-a-Dish": Mechanistic Insights and Drug Development Using iPSC-Based Disease Modeling.主动脉“盘中疾病”:基于诱导多能干细胞的疾病建模的机制洞察与药物开发
Front Cell Dev Biol. 2020 Oct 28;8:550504. doi: 10.3389/fcell.2020.550504. eCollection 2020.
5
Treatment of a middle cerebral artery aneurysm in the setting of Loeys-Dietz syndrome: Case report and review of literature.洛伊-迪茨综合征患者大脑中动脉瘤的治疗:病例报告及文献综述
Radiol Case Rep. 2020 Oct 30;16(1):48-50. doi: 10.1016/j.radcr.2020.10.012. eCollection 2021 Jan.
6
Meta-analysis Examining the Usefulness of Angiotensin Receptor blockers for the Prevention of Aortic Root Dilation in Patients With the Marfan Syndrome.Meta 分析研究血管紧张素受体阻滞剂在马凡综合征患者预防主动脉根部扩张中的作用。
Am J Cardiol. 2020 Aug 1;128:101-106. doi: 10.1016/j.amjcard.2020.04.034. Epub 2020 May 19.
7
Long-term clinical outcomes of losartan in patients with Marfan syndrome: follow-up of the multicentre randomized controlled COMPARE trial.氯沙坦治疗马凡综合征患者的长期临床结局:多中心随机对照 COMPARE 试验的随访。
Eur Heart J. 2020 Nov 14;41(43):4181-4187. doi: 10.1093/eurheartj/ehaa377.
8
Aortic arch geometry predicts outcome in patients with Loeys-Dietz syndrome independent of the causative gene.升主动脉弓形态学预测洛伊茨-迪茨综合征患者的结局与致病基因无关。
Am J Med Genet A. 2020 Jul;182(7):1673-1680. doi: 10.1002/ajmg.a.61608. Epub 2020 Apr 30.
9
Biomarkers of Aortopathy in Marfan Syndrome.马凡综合征中主动脉病变的生物标志物
Cardiol Rev. 2020 Mar/Apr;28(2):92-97. doi: 10.1097/CRD.0000000000000289.
10
Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial.马凡综合征中应用厄贝沙坦(AIMS):一项双盲、安慰剂对照随机试验。
Lancet. 2019 Dec 21;394(10216):2263-2270. doi: 10.1016/S0140-6736(19)32518-8. Epub 2019 Dec 10.